Gene Therapy - Cell Therapy - Regulatory Consulting Firm for Sale
Cell and Gene Therapy Regulatory Consulting Firm in Los Angeles, CA
On NextCompany since September 10, 2026 (34 days)
Los Angeles, CA areaEstablished 20111 FT employees
Business overview
This Los Angeles, CA consulting firm advises clients on cell and gene therapy. Its services cover strategy, quality checks, regulatory meetings, and submissions. The business has operated since 2011. It served 110+ customers over six years across biotech, pharma, healthcare, consulting, and government.
The firm reports $3,500,000 in gross revenue and $1,250,000 in cash flow. Net income grew from $179,000 in 2019 to $1,095,000 in 2021. Its staffing includes 1 full-time employee and nationwide contractors. The seller seeks a growth partner and offers a long-term transition with continued growth support.
Who is a good fit for this business
- Strategic acquirers seeking cell and gene therapy advisory capabilities.
- Buyers seeking a relocatable business that accommodates ownership from worldwide locations.
- Growth partners seeking continued seller involvement through a long-term transition.
Details
- Reason for selling
- Growth.
Frequently Asked Questions
The firm advises on strategy, quality checks, regulatory meetings, and submissions for cell and gene therapy. It serves biotech companies, pharma companies, healthcare providers, consulting firms, and government organizations.
The business reports gross revenue of $3,500,000 and cash flow of $1,250,000. It grew net income from $179,000 in 2019 to $1,095,000 in 2021.
The firm combines 1 full-time employee with nationwide contractors. It maintains US headquarters, supports relocation, and accommodates a buyer located worldwide.
The seller seeks a growth partner for the business. The seller offers a long-term transition and continued growth support.
The seller considers financing if the price and deal structure are right. Those terms determine the seller's willingness to finance.